Technology News

Ex Solvay CEO Starts New Biotech

Monday, December 04, 2006 9:00:00 AM PDT | VentureDeal Staff

ATLANTA, GA --  Prominent CEO Harold Shlevin is launching a biopharmaceutical startup to focus on diseases of the central nervous system.

His company, called Tikvah Therapeutics, will explore new uses for already approved compounds in order to shorten product development timelines.

The company expects to receive a loan from Georgia's Life Sciences Facilities Fund to assist in securing lab and office facilities.  It was founded with support of Paramount Biosciences.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1